AAAAAA
Results:
1-24
|
Results: 24
Authors:
Vile, RG
Citation: Rg. Vile, Vironcology - not yet, but soon? - Engineering the regulatory pathways of a replicating oncolytic adenovirus enhances selective destruction of tumor cells., NAT BIOTECH, 19(11), 2001, pp. 1020-1022
Authors:
Harrington, KJ
Mohammadtaghi, S
Uster, PS
Glass, D
Peters, AM
Vile, RG
Stewart, JSW
Citation: Kj. Harrington et al., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes, CLIN CANC R, 7(2), 2001, pp. 243-254
Authors:
Harrington, KJ
Lewanski, C
Northcote, AD
Whittaker, J
Peters, AM
Vile, RG
Stewart, JSW
Citation: Kj. Harrington et al., Phase II study of pegylated liposomal doxorubicin (Caelyx (TM)) as induction chemotherapy for patients with squamous cell cancer of the head and neck, EUR J CANC, 37(16), 2001, pp. 2015-2022
Authors:
Harrington, KJ
Lewanski, CR
Northcote, AD
Whittaker, J
Wellbank, H
Vile, RG
Peters, AM
Stewart, JSW
Citation: Kj. Harrington et al., Phase I-II study of pegylated liposomal cisplatin (SPI-077 (TM)) in patients with inoperable head and neck cancer, ANN ONCOL, 12(4), 2001, pp. 493-496
Authors:
Harrington, KJ
Rowlinson-Busza, G
Syrigos, KN
Uster, PS
Vile, RG
Peters, AM
Stewart, JSW
Citation: Kj. Harrington et al., The effect of irradiation on the biodistribution of radiolabeled pegylatedliposomes, INT J RAD O, 50(3), 2001, pp. 809-820
Authors:
Harrington, KJ
Rowlinson-Busza, G
Uster, PS
Vile, RG
Peters, AM
Stewart, JSW
Citation: Kj. Harrington et al., Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model, INT J RAD O, 49(4), 2001, pp. 1141-1148
Authors:
Harrington, KJ
Spitzweg, C
Bateman, AR
Morris, JC
Vile, RG
Citation: Kj. Harrington et al., Gene therapy for prostate cancer: Current status and future prospects, J UROL, 166(4), 2001, pp. 1220-1233
Authors:
Spitzweg, C
Harrington, KJ
Pinke, LA
Vile, RG
Morris, JC
Citation: C. Spitzweg et al., The sodium iodide symporter and its potential role in cancer therapy, J CLIN END, 86(7), 2001, pp. 3327-3335
Authors:
Gough, MJ
Melcher, AA
Ahmed, A
Crittenden, MR
Riddle, DS
Linardakis, E
Ruchatz, AN
Emiliusen, LM
Vile, RG
Citation: Mj. Gough et al., Macrophages orchestrate the immune response to tumor cell death, CANCER RES, 61(19), 2001, pp. 7240-7247
Authors:
Bateman, AR
Harrington, KJ
Melcher, AA
Vile, RG
Citation: Ar. Bateman et al., Cancer gene therapy: developments to 2000, EXPERT OP I, 9(12), 2000, pp. 2799-2813
Authors:
Harrington, KJ
Rowlinson-Busza, G
Syrigos, KN
Uster, PS
Vile, RG
Stewart, JSW
Citation: Kj. Harrington et al., Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery, CLIN CANC R, 6(6), 2000, pp. 2528-2537
Authors:
Harrington, KJ
Rowlinson-Busza, G
Syrigos, KN
Vile, RG
Uster, PS
Peters, AM
Stewart, JSW
Citation: Kj. Harrington et al., Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model, CLIN CANC R, 6(12), 2000, pp. 4939-4949
Authors:
Diaz, RM
Bateman, A
Emiliusen, L
Fielding, A
Trono, D
Russell, SJ
Vile, RG
Citation: Rm. Diaz et al., A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy, GENE THER, 7(19), 2000, pp. 1656-1663
Authors:
Melero, I
Vile, RG
Colombo, MP
Citation: I. Melero et al., Feeding dendritic cells with tumor antigens: self-service buffet or a la carte?, GENE THER, 7(14), 2000, pp. 1167-1170
Authors:
Vile, RG
Russell, SJ
Lemoine, NR
Citation: Rg. Vile et al., Cancer gene therapy: hard lessons and new courses, GENE THER, 7(1), 2000, pp. 2-8
Authors:
Harrington, KJ
Linardakis, E
Vile, RG
Citation: Kj. Harrington et al., Transcriptional control: An essential component of cancer gene therapy strategies?, ADV DRUG DE, 44(2-3), 2000, pp. 167-184
Authors:
Todryk, SM
Melcher, AA
Dalgleish, AG
Vile, RG
Citation: Sm. Todryk et al., Heat shock proteins refine the danger theory, IMMUNOLOGY, 99(3), 2000, pp. 334-337
Authors:
Bateman, A
Bullough, F
Murphy, S
Emiliusen, L
Lavillette, D
Cosset, FL
Cattaneo, R
Russell, SJ
Vile, RG
Citation: A. Bateman et al., Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth, CANCER RES, 60(6), 2000, pp. 1492-1497
Authors:
Higuchi, H
Bronk, SF
Bateman, A
Harrington, K
Vile, RG
Gores, GJ
Citation: H. Higuchi et al., Viral fusogenic membrane glycoprotein expression causes syncytia formationwith bioenergetic cell death: Implications for gene therapy, CANCER RES, 60(22), 2000, pp. 6396-6402
Authors:
Bateman, A
Bullough, F
Murphy, S
Emiliusen, L
Lavillette, D
Cosset, FL
Cattaneo, R
Russell, SJ
Vile, RG
Citation: A. Bateman et al., Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth (vol 60, pg 1492, 2000), CANCER RES, 60(17), 2000, pp. 4978-4978
Authors:
Peng, KW
Vile, RG
Cosset, FL
Russell, SJ
Citation: Kw. Peng et al., Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors, GENE THER, 6(9), 1999, pp. 1552-1557
Authors:
Todryk, S
Melcher, AA
Hardwick, N
Linardakis, E
Bateman, A
Colombo, MP
Stoppacciaro, A
Vile, RG
Citation: S. Todryk et al., Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake, J IMMUNOL, 163(3), 1999, pp. 1398-1408
Authors:
Melcher, A
Todryk, S
Bateman, A
Chong, H
Lemoine, NR
Vile, RG
Citation: A. Melcher et al., Adoptive transfer of immature dendritic cells with autologous or allogeneic tumor cells generates systemic antitumor immunity, CANCER RES, 59(12), 1999, pp. 2802-2805
Authors:
Alexandroff, AB
McIntyre, CA
Porter, JC
Zeuthen, J
Vile, RG
Taub, DD
Citation: Ab. Alexandroff et al., Sticky and smelly issues: lessons on tumour cell and leucocyte trafficking, gene and immunotherapy of cancer, BR J CANC, 77(11), 1998, pp. 1806-1811
Risultati:
1-24
|